CVS Health
CVS
1,780 hedge funds and large institutions have $69.6B invested in CVS Health in 2018 Q4 according to their latest regulatory filings, with 301 funds opening new positions, 895 increasing their positions, 486 reducing their positions, and 102 closing their positions.
195% more first-time investments, than exits
New positions opened: 301 | Existing positions closed: 102
84% more repeat investments, than reductions
Existing positions increased: 895 | Existing positions reduced: 486
46% more call options, than puts
Call options by funds: $1.13B | Put options by funds: $775M
11% more funds holding
Funds holding: 1,599 → 1,780 (+181)
5% more funds holding in top 10
Funds holding in top 10: 79 → 83 (+4)
1% more capital invested
Capital invested by funds: $68.8B → $69.6B (+$784M)
3.74% less ownership
Funds ownership: 85.9% → 82.16% (-3.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.82B |
| 2 |
BlackRock
New York
|
+$1.25B |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.25B |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$846M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$704M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIG
American International Group
New York
|
-$433M |
| 2 |
Parnassus Investments
San Francisco,
California
|
-$200M |
| 3 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$94.6M |
| 4 |
Harris Associates
Chicago,
Illinois
|
-$93.3M |
| 5 |
N
Natixis
Paris,
France
|
-$91.2M |
CVS Hedge Fund Activity: Q4 2018 in Review
1,780 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2018, worth a combined $69.6B — up 1.1% from $68.8B a quarter earlier.
Buyers outnumbered sellers: 301 funds opened new CVS positions and 102 closed out — a net gain of 199 holders — while 895 added to existing stakes and 486 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.82B. The largest seller was American International Group, cutting an estimated $433M.
- 1,780 institutional investors held CVS Health (CVS) as of Q4 2018, up from 1,599 in Q3 2018.
- Funds reported $69.6B of CVS Health stock for Q4 2018, up 1.1% quarter-over-quarter.
- 301 funds opened new CVS Health positions in Q4 2018 and 102 closed out, a net change of +199 holders.
- The largest CVS Health buyer in Q4 2018 was Vanguard Group, an estimated $1.82B added.
- The largest CVS Health seller in Q4 2018 was American International Group, an estimated $433M sold.
Based on aggregated 13F filings for Q4 2018.